FTLF — FitLife Brands, Inc.

FitLife Brands (FTLF) Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Total Revenue: $25.9 million, up 73% year-over-year, primarily due to the acquisition of Irwin Naturals.
• Wholesale Revenue: $15.5 million (60% of total revenue), increased 213% year-over-year.
• Online Revenue: $10.5 million (40% of total revenue), a 4% increase year-over-year.
• Gross Margin: 37.0%, down from 41.4% in Q4 2024, largely due to Irwin's lower historical margins.
• Net Income: $1.6 million, down from $2.1 million in Q4 2024, impacted by transaction-related expenses.
• Adjusted EBITDA: $3.5 million, a 14% increase from Q4 2024.
• Legacy FitLife Revenue: $13.3 million, a 12% decrease year-over-year, with declines in both wholesale (14%) and online (10%) segments.

2. Strategic Updates and Business Highlights

• Irwin Naturals Acquisition: First full quarter results included; normalized revenue for 2025 was flat at $54 million after adjusting for lost customers (Costco, Rite Aid) and discontinued CBD products.
• Supply Chain Improvements: Focus on transitioning to 3-year shelf life for products to reduce inventory obsolescence, which could enhance gross margins significantly.
• New Product Development: Three new products are in production, expected to launch in Q3 2026.
• Marketing Initiatives: Increased focus on off-Amazon marketing, including partnerships and social media advertising, particularly for the Dr. Tobias brand.
• Debt Reduction: Paid down $1.9 million in debt during Q4, with ongoing efforts to reduce indebtedness.

3. Forward Guidance and Outlook

• 2026 Outlook: No formal guidance provided due to ongoing uncertainty and weakness in Q1 2026. The company is cautious about the impact of macroeconomic conditions on consumer spending.
• Irwin's Online Growth: Encouraging growth with monthly revenue reaching approximately $800,000 by March 2026, indicating potential for a $9-$10 million annual run rate.

4. Bad News, Challenges, or Points of Concern

• Consumer Sentiment: Declining consumer discretionary spending and confidence, impacting overall sales.
• Legacy FitLife Weakness: Broad-based weakness across brands, particularly in MRC and MusclePharm, with total revenue declines noted.
• Irwin's Margin Challenges: Lower gross margins compared to legacy FitLife brands, with expectations of gradual improvement.
• Amazon Algorithm Changes: Shift in Amazon's algorithm affecting subscriber counts and sales, particularly for brands heavily reliant on Amazon.

5. Notable Q&A Insights

• Revenue Headwinds: CEO Dayton Judd noted challenges in isolating the impact of Amazon's changes versus broader market conditions, indicating both are contributing to revenue softness.
• Gross Margin Expectations: Judd indicated that while Irwin's margins are currently low, there is potential for improvement, aiming for mid to high 30% margins over time.
• MusclePharm's Recovery: Judd acknowledged the difficulties in revitalizing MusclePharm, emphasizing that while there are growth opportunities, expectations should be tempered regarding its return to previous revenue levels.
• CBD Product Exit: The decision to discontinue CBD products was driven by complex legal challenges rather than margin considerations, as CBD products had previously been profitable.

This summary encapsulates the key points from the earnings call, highlighting both the successes and challenges faced by FitLife Brands as they navigate the current market landscape.